The development of abnormal skin cell growth is also known as skin cancer which is also called as Dermatological Oncology. Skin cancer has the ability to invade to other parts of the body through blood vessels. Dermatological Oncology widely classified into Non-Melanoma Skin Cancer (NMSC) and Melanoma Skin Cancer (MSC). Despite the fact that melanoma is one of the most rapidly increasing forms of human cancer, new treatments have been slow in developing and the mortality rate continues to rise. There are more than 90% of skin cancers has caused by radiations (Ultra Violet) and 20 to 30% of MSC developed from the mole.
Globally most common type of dermatological oncology is NMSC, around 2-3 million people were affected by the NMSC. In that 80% are Basal-Cell Cancer and 20% are Squamous-Cell Cancer. Non-Melanoma Skin Cancer cells very rarely causing death. But, in 2012 around 232000 people affected by Melanoma Skin Cancer and resulted in 55000 deaths. According to Australian Cancer Research Foundation (ACRF), 2 in 3 Australians has diagnosed with skin cancer by the time they are at 70, and more than 750,000 people treated for one or more non-melanoma skin cancers in each year. In 2013, 12,744 Australians were diagnosed with melanoma. In 2014, 2067 people died from skin cancer in that 1467 from melanoma skin cancer and 600 from non-melanoma skin cancers.
Related Dermatology Conferences |Dermatology Meetings| Dermatology Events: Dermatology Aesthetic & Clinical Conference, 12-15th January, 2018 National Doral Miami, USA; 42nd Annual Hawaii Dermatology Seminar,4-9th February, 2018 Koloa, USA; 5th World Congress of Dermoscopy, 14-16th June, 2018 Thessaloniki, Greece, UK.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
